An Open Label, Randomised, Single Dose, 3-way Cross Over Study to Investigate Relative Bioavailability and Food Effect on Different Formulations of BI 113608 in Healthy Male Subjects, Followed by Fixed Sequence Periods Investigating Influence of Pantoprazole Coadministration and Food Effect on Pharmacokinetics of Different Formulations of BI 113608
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
Price : $35 *
At a glance
- Drugs BI 113608 (Primary) ; Pantoprazole
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 06 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jan 2013 Planned End Date changed from 1 Feb 2013 to 1 Jan 2013 as reported by ClinicalTrials.gov.
- 08 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.